Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1993 Feb;46(2):189. doi: 10.1136/jcp.46.2.189-a

AgNOR quantification in tumour pathology: what is actually evaluated?

D Trerè
PMCID: PMC501161  PMID: 8459045

Full text

PDF

Page 189

189

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cheville J. C., Clamon G. H., Robinson R. A. Silver-stained nucleolar organizer regions in the differentiation of prostatic hyperplasia, intraepithelial neoplasia, and adenocarcinoma. Mod Pathol. 1990 Sep;3(5):596–598. [PubMed] [Google Scholar]
  2. Crocker J., Boldy D. A., Egan M. J. How should we count AgNORS? Proposals for a standardized approach. J Pathol. 1989 Jul;158(3):185–188. doi: 10.1002/path.1711580303. [DOI] [PubMed] [Google Scholar]
  3. Giri D. D., Nottingham J. F., Lawry J., Dundas S. A., Underwood J. C. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry. J Pathol. 1989 Apr;157(4):307–313. doi: 10.1002/path.1711570407. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES